Body mass index and adult weight gain among reproductive age women with migraine.

Abstract:

OBJECTIVE:To evaluate the cross-sectional relationship between migraine and pregravid obesity; and to assess the risk of adult weight gain among women with history of a pediatric diagnosis of migraine. BACKGROUND:Obesity, comorbid with pain disorders including migraine, shares common pathophysiological characteristics including systemic inflammation, and derangements in adipose-tissue derived cytokines. Despite biochemical and epidemiological commonalities, obesity-migraine associations have been inconsistently observed. METHODS:A cohort of 3733 women was interviewed during early pregnancy. We ascertained participants' self-reported history of physician-diagnosed migraine and collected self-reported information about pregravid weight, adult height, and net weight change from age 18 to the 3-months period before pregnancy. Using pregravid body mass index, we categorized participants as follows: lean (< 18.5 kg/m²), normal (18.5-24.9 kg/m²), overweight (25-29.9 kg/m²), obese (30-34.9 kg/m²), severely obese (35-39.9 kg/m²), and morbidly obese (≥ 40 kg/m²). Logistic regression procedures were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS:After adjusting for confounders, relative to normal weight women, obese women had a 1.48-fold increased odds of migraine (OR = 1.48; 95% CI 1.12-1.96). Severely obese (OR = 2.07; 95% CI 1.27-3.39) and morbidly obese (OR = 2.75; 95% CI 1.60-4.70) had the highest odds of migraines. Women with a history of diagnosed pediatric migraine had a 1.67-fold higher odds of gaining ≥ 10.0 kg above their weight at age 18, as compared with non-migraineurs (OR = 1.67; 95% CI 1.13-2.47). CONCLUSION:These data support earlier observations of migraine-obesity association among women, and extend the literature to include evidence of adult weight gain among women with a history of pediatric migraine.

journal_name

Headache

journal_title

Headache

authors

Vo M,Ainalem A,Qiu C,Peterlin BL,Aurora SK,Williams MA

doi

10.1111/j.1526-4610.2010.01833.x

subject

Has Abstract

pub_date

2011-04-01 00:00:00

pages

559-69

issue

4

eissn

0017-8748

issn

1526-4610

journal_volume

51

pub_type

杂志文章,多中心研究

相关文献

HEADACHE文献大全
  • Intravenous lidocaine in the treatment of refractory headache: a retrospective case series.

    abstract:BACKGROUND:New treatments are needed to treat chronic daily headache (CDH) and chronic cluster headache (CCH). New treatments are needed to treat this population and intravenous (IV) lidocaine is a novel treatment for CDH. OBJECTIVE:The aim of this study was to examine the use of IV lidocaine for refractory CDH patien...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.2008.01281.x

    authors: Rosen N,Marmura M,Abbas M,Silberstein S

    更新日期:2009-02-01 00:00:00

  • Understanding the patient with migraine: the evolution from episodic headache to chronic neurologic disease. A proposed classification of patients with headache.

    abstract::Traditionally, episodic primary headache disorders are characterized by a return of preheadache (normal) neurologic function between episodes of headache. In contrast, patients with chronic headache often do not return to normal neurologic function between headache attacks. This article proposes that the evolution fro...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.2004.04094.x

    authors: Cady RK,Schreiber CP,Farmer KU

    更新日期:2004-05-01 00:00:00

  • No microstructural white matter alterations in chronic and episodic migraineurs: a case-control diffusion tensor magnetic resonance imaging study.

    abstract:BACKGROUND:In patients with episodic migraine (EM), diffusion tensor imaging (DTI) revealed microstructural white matter alterations in various brain regions related to pain processing. Some of these changes were correlated with migraine duration and attack frequency, suggesting that migraine is a progressive disease w...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/head.12496

    authors: Neeb L,Bastian K,Villringer K,Gits HC,Israel H,Reuter U,Fiebach JB

    更新日期:2015-02-01 00:00:00

  • A clinical study of migraine evolution.

    abstract:BACKGROUND:The buildup time of migraine headaches has not been well delineated in publications to date and we are aware of patients whose migraines last well over 72 hours. More concentration on these factors in the assessment of patients might lead to more appropriate therapeutic choices. METHOD:Prospective ascertain...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.2006.00608.x

    authors: Pryse-Phillips W,Aubé M,Bailey P,Becker WJ,Bellavance A,Gawel M,Giammarco R,Mackie G,Purdy RA,Robinson G,Shapero G,Wilson K

    更新日期:2006-11-01 00:00:00

  • Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.

    abstract:OBJECTIVE:To compare the efficacy and tolerability of sumatriptan nasal spray (NS) (5, 20 mg) versus placebo in the acute treatment of migraine in adolescent subjects. BACKGROUND:Currently, no triptan is approved in the United States for the treatment of migraine in adolescent subjects (12 to 17 years). In a previous ...

    journal_title:Headache

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1111/j.1526-4610.2006.00339.x

    authors: Winner P,Rothner AD,Wooten JD,Webster C,Ames M

    更新日期:2006-02-01 00:00:00

  • One-year follow-up of headache in an adult general population.

    abstract:OBJECTIVE:To investigate variation in headache occurrence and characteristics over 1 year. BACKGROUND:Headache is a common condition which can affect the work, home, and social lives of sufferers, yet surprisingly little is known about how headache changes over time. METHODS:Postal survey to a random general populati...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.2005.05071.x

    authors: Boardman HF,Thomas E,Millson DS,Croft PR

    更新日期:2005-04-01 00:00:00

  • SUNCT syndrome. Two cases in Argentina.

    abstract::Two patients suffering from SUNCT syndrome are presented. Some features are remarkable. The first patient was a 69-year-old man whose first crisis was located in the right supraorbital region. After a 4-month spontaneous remission, the pain returned to the upper part of the cheek, radiating to the supraciliary region ...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1046/j.1526-4610.1998.3805369.x

    authors: Raimondi E,Gardella L

    更新日期:1998-05-01 00:00:00

  • Successful use of propranolol in migraine associated with electroconvulsive therapy.

    abstract::To date, there have been no reports on the use of propranolol in electroconvulsive therapy (ECT)-induced migraine; we describe a 32-year-old woman who was successfully treated with propranolol for this condition. Over a course of ECT, the patient developed increasingly severe migraine which was refractory to treatment...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1046/j.1526-4610.2001.111006092.x

    authors: Hawken ER,Delva NJ,Lawson JS

    更新日期:2001-01-01 00:00:00

  • Impact of the International Headache Society criteria on the use of neuroimaging for headache diagnosis in a headache clinic.

    abstract:OBJECTIVE:To evaluate the impact of the introduction of the International Headache Society (IHS) criteria on the use of neuroimaging for headache diagnosis in a specialist outpatient center. BACKGROUND:The general indications for neuroimaging in headache are a matter of debate. International Headache Society criteria ...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1046/j.1526-4610.1999.3910747.x

    authors: Fabbrini G,Barbanti P,Pascali MP,Lenzi GL,Cerbo R

    更新日期:1999-11-01 00:00:00

  • Privacy Issues in Smartphone Applications: An Analysis of Headache/Migraine Applications.

    abstract:BACKGROUND:Headache diaries are a mainstay of migraine management. While many commercial smartphone applications (apps) have been developed for people with migraine, little is known about how well these apps protect patient information and whether they are secure to use. OBJECTIVE:We sought to assess whether there are...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/head.13341

    authors: Minen MT,Stieglitz EJ,Sciortino R,Torous J

    更新日期:2018-07-01 00:00:00

  • Transient Global Amnesia Triggered by Migraine in a French Tertiary-Care Center: An 11-Year Retrospective Analysis.

    abstract:OBJECTIVE:The etiology of transient global amnesia (TGA) remains unclear, and flow disturbances in the mesial temporal lobes secondary to venous congestion have been proposed as a potential cause. The occurrence of TGA during a migraine attack is a rare condition. METHODS:This 11-year retrospective study in one French...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/head.12545

    authors: Donnet A

    更新日期:2015-06-01 00:00:00

  • A 3-month analysis of disability, quality of life, and disease course in patients with migraine.

    abstract:OBJECTIVE:To describe a short-term "real-life" longitudinal evolution of migraine course, quality of life, and disability in a sample of patients attending to a specialty center and to evaluate the association between the changes in patient-reported outcomes, number of reported headaches, their severity, and treatment ...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.2012.02279.x

    authors: Raggi A,Leonardi M,Bussone G,D'Amico D

    更新日期:2013-02-01 00:00:00

  • Familial hemiplegic migraine with crossed cerebellar diaschisis and unilateral meningeal enhancement.

    abstract::A 6-year-old boy with a family history of hemiplegic migraine had a hemiplegic migraine lasting for 6 days complicated by prolonged fever, lethargy, and two brief focal seizures. An acute single photon emission computerized tomogram (SPECT) demonstrated decreased blood flow in the symptomatic cerebral hemisphere as we...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1046/j.1526-4610.1997.3709590.x

    authors: Crawford JS,Konkol RJ

    更新日期:1997-10-01 00:00:00

  • Verapamil for cluster headache. Clinical pharmacology and possible mode of action.

    abstract::Verapamil is used mainly in cardiovascular diseases. High-dose verapamil (360-720 mg) is, however, currently the mainstay in the prophylactic treatment of cluster headache. The oral pharmacokinetics are variable. The pharmacodynamic effect of verapamil, the effect on blood pressure, also varies considerably among subj...

    journal_title:Headache

    pub_type: 杂志文章,评审

    doi:10.1111/j.1526-4610.2008.01298.x

    authors: Tfelt-Hansen P,Tfelt-Hansen J

    更新日期:2009-01-01 00:00:00

  • Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial.

    abstract:OBJECTIVE:To evaluate the long-term tolerability of telcagepant for acute treatment of intermittent migraine attacks. Background.- Telcagepant is a calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the acute treatment of migraine. METHODS:Migraine patients were randomized 2:1 to double-...

    journal_title:Headache

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/j.1526-4610.2010.01799.x

    authors: Connor KM,Aurora SK,Loeys T,Ashina M,Jones C,Giezek H,Massaad R,Williams-Diaz A,Lines C,Ho TW

    更新日期:2011-01-01 00:00:00

  • Individual differences in the subjective experience of pain: new insights into mechanisms and models.

    abstract::Individual differences in pain sensitivity have long remained a perplexing and challenging clinical problem. How can one individual have a sensory experience that is vastly different than that of another, even when they have received similar sensory input? Developing an understanding of such differences and the mechan...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.2010.01763.x

    authors: Coghill RC

    更新日期:2010-10-01 00:00:00

  • MRA captures vasospasm in fatal migrainous infarction.

    abstract::A 57-year-old woman presented with an escalation of her headaches which ultimately progressed to multiple strokes and death. MRI/MRA demonstrated diffuse vasospasm and other causes of stroke were excluded on premortem investigation and postmortem examination. Reversible MRI abnormalities, vasospasm on angiogram and fa...

    journal_title:Headache

    pub_type: 信件

    doi:10.1111/j.1526-4610.2007.00695.x

    authors: Marshall N,Maclaurin WA,Koulouris G

    更新日期:2007-02-01 00:00:00

  • Faster Improvement in Migraine Pain Intensity and Migraine-Related Disability at Early Time Points with AVP-825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from the CO

    abstract:BACKGROUND:Fast relief of migraine pain, associated symptoms, and migraine-related disability are priorities in the acute treatment of migraine. Efforts to improve the pharmacokinetic profiles of acute migraine treatments with the aim of providing faster relief include the development of non-oral routes of administrati...

    journal_title:Headache

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/head.13165

    authors: Lipton RB,McGinley JS,Shulman KJ,Wirth RJ,Buse DC

    更新日期:2017-11-01 00:00:00

  • Reduced sensitivity of lymphocyte beta-adrenergic receptors in migraine.

    abstract::Cyclic AMP (CAMP) accumulation induced by isoproterenol (IP) and forskolin in intact lymphocytes was determined in 12 patients with migraine and 12 healthy controls. Our data showed that IP CAMP accumulation (8.20 + 1.08 Pmol/million cells) was significantly (P = 0.033) lower than accumulation in the controls (14.39 +...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.1993.hed33040198.x

    authors: Kuritzky A,Bennet E,Hering R,Ebstein R

    更新日期:1993-04-01 00:00:00

  • Predictability of exogenous hormone effect on subgroups of migraineurs.

    abstract:OBJECTIVE:To evaluate whether self-reported past migraine response to reproductive life events (menses, pregnancy, menopause) alters the likelihood of worsening of migraine with exogenous hormone use. METHODS:A retrospective study was conducted on 451 female patients at the University Headache Center who had a diagnos...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1046/j.1526-4610.2000.00027.x

    authors: Mueller L

    更新日期:2000-03-01 00:00:00

  • Ischemic colitis associated with naratriptan and oral contraceptive use.

    abstract::Ischemic colitis has not been reported in association with naratriptan therapy. We describe the occurrence of ischemic colitis in a patient who was treated with abortive doses of naratriptan for migraine and was also taking long-term oral contraceptives. Concurrent use of naratriptan and oral contraceptives should pro...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.2005.05077_4.x

    authors: Charles JA,Pullicino PM,Stoopack PM,Shroff Y

    更新日期:2005-04-01 00:00:00

  • Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective "real-world" study.

    abstract:BACKGROUND AND OBJECTIVES:Certain neuromodulators, most notably topiramate (TPM) and divalproex sodium (DVP), are effective preventive agents for migraine. Published data from head-to-head studies comparing TPM and DVP are not available. The purpose of this study was to compare TPM and DVP for the prophyaxis of migrain...

    journal_title:Headache

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1111/j.1526-4610.2011.01868.x

    authors: Krymchantowski AV,Jevoux CC

    更新日期:2011-04-01 00:00:00

  • Pathophysiology of chronic migraine and mode of action of preventive medications.

    abstract::Evidence has accumulated in recent years indicating structural, physiologic, and biochemical alterations in the brain of patients with chronic migraine (CM). Altered pharmacologic responses to opioids and other analgesics have also been reported. Structural or morphologic changes include reduced cortical gray matter o...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.2011.01955.x

    authors: Mathew NT

    更新日期:2011-07-01 00:00:00

  • Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness?

    abstract:OBJECTIVE:The periaqueductal gray matter (PAG) is at the center of a powerful descending antinociceptive neuronal network. We studied iron homeostasis in the PAG as an indicator of function in patients with episodic migraine (EM) between attacks and patients with chronic daily headache (CDH) during headache. High-resol...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1046/j.1526-4610.2001.041007629.x

    authors: Welch KM,Nagesh V,Aurora SK,Gelman N

    更新日期:2001-07-01 00:00:00

  • Olanzapine in the treatment of refractory migraine and chronic daily headache.

    abstract:BACKGROUND:Olanzapine, a thienobenzodiazepine, is a new "atypical" antipsychotic drug. Olanzapine's pharmacologic properties suggest it would be effective for headaches, and its propensity for inducing acute extrapyramidal reactions or tardive dyskinesia is relatively low. We thus decided to assess the value of olanzap...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1046/j.1526-4610.2002.02126.x

    authors: Silberstein SD,Peres MF,Hopkins MM,Shechter AL,Young WB,Rozen TD

    更新日期:2002-06-01 00:00:00

  • Cutaneous atrophy and alopecia after greater occipital nerve injection using triamcinolone.

    abstract::Greater occipital nerve (GON) infiltration is widely used for the treatment of primary and secondary headache disorders mainly on the basis of open-label evidence, although recent double-blinded placebo-controlled trials have demonstrated its efficacy in cluster headache. The procedure is generally well tolerated alth...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.2012.02270.x

    authors: Lambru G,Lagrata S,Matharu MS

    更新日期:2012-11-01 00:00:00

  • A piroxicam derivative partly effective in chronic paroxysmal hemicrania and hemicrania continua.

    abstract::Piroxicam beta-cyclodextrin has recently been observed to be equal to, or even possibly to be superior to, indomethacin (mainly with regard to side effects) in a single case of hemicrania continue. Piroxicam beta-cyclodextrin, 20 to 40 mg per day, was, accordingly, tried in six patients with chronic paroxysmal hemicra...

    journal_title:Headache

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1526-4610.1995.hed3509549.x

    authors: Sjaastad O,Antonaci F

    更新日期:1995-10-01 00:00:00

  • Analgesic rebound headache in clinical practice: data from a physician survey.

    abstract:BACKGROUND:Frequent, excessive use of over-the-counter or prescription analgesics may lead to analgesic rebound headache. Little is known about the magnitude of the health problem posed by analgesic rebound headache, its epidemiology, the characteristics of analgesic rebound headache sufferers, or about physicians' app...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1046/j.1526-4610.1996.3601014.x

    authors: Rapoport A,Stang P,Gutterman DL,Cady R,Markley H,Weeks R,Saiers J,Fox AW

    更新日期:1996-01-01 00:00:00

  • Cerebrovascular reactivity in adolescents with migraine and tension-type headache during headache-free interval and attack.

    abstract:BACKGROUND:Migraine is a common cause of headache in adolescents. Assuming that the cerebral vasculature is involved in the pathophysiology of migraine, we compared cerebral vasoreactivity in adolescents both during a migraine attack and a headache-free interval. METHODS:A functional transcranial Doppler test utilizin...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1046/j.1526-4610.2003.03090.x

    authors: Rosengarten B,Sperner J,Görgen-Pauly U,Kaps M

    更新日期:2003-05-01 00:00:00

  • Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial.

    abstract:OBJECTIVE:To address the need for a rigorous, direct comparison of prescription and over-the-counter (OTC) migraine drugs and to expand the database on early treatment of migraine. BACKGROUND:Most people who experience migraine use OTC medications to treat their symptoms, but no head-to-head clinical trials comparing ...

    journal_title:Headache

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1111/j.1526-4610.2005.05177.x

    authors: Goldstein J,Silberstein SD,Saper JR,Elkind AH,Smith TR,Gallagher RM,Battikha JP,Hoffman H,Baggish J

    更新日期:2005-09-01 00:00:00